AutoGenomics Company
AutoGenomics, Inc., a privately held company based in Vista, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genetic biomarkers in the areas of women's health, cancer and personalized medicine. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to a new era of personalized medicine.
Founded Date:
2013
Funding Status:
Venture - Series Unknown
Total Funding:
$67 M
Technology:
Biomarkers of General Women's Health Biomarkers, Biomarkers of Female Reproductive Health
Estimated Revenue:
$10M to $50M
Headquarters:
Vista, California, United States
Last Funding Type:
Venture - Series Unknown
Industry:
Women Cancer Treatment
Last Funding Date:
2013-01-11